CURRENT ANTI-OBESITY PHARMACOTHERAPY Anti-obesity pharmacotherapy is indicated as an adjunct to lifestyle interventions in adults with a BMI 30 kg/m 2 or a BMI 27 kg/m 2 in patients with additional weight-related comorbidities
Neumann A, Berends ET, Nerlich A, Molhoek EM, Gallo RL, Meerloo T, Nizet V, Naim HY, von Kockritz-Blickwede M (2014) The antimicrobial peptide LL-37 facilitates the formation of neutrophil extracellular traps
Monoclonal Antibody Therapy for the Treatment of Interstitial Cystitis
You can return to your work if it is not physically demanding
Featuring Ascorbic Acid (Vitamin C), Glutathione, and Thiotic Acid, these products provide antioxidant effects and help with fatigue recovery
Hydrolysis begins